Solvex Edibles Ltd

Solvex Edibles Ltd

₹ 64.6 None%
01 Oct - close price
About

Incorporated in 2013, Solvex Edibles Limited is engaged in the business of manufacturing, distribution, marketing, and selling of Solvent Extracted Rice Bran Oil and other by-products.[1]

Key Points

Business Profile[1]
The company manufactures, distributes, markets, and sells solvent-extracted rice bran oil, along with by-products such as de-oiled rice bran (DORB), rice bran, mustard oil, mustard cakes, and de-oiled mustard cakes. Its products are primarily supplied to FMCG companies rather than under its own brand, while the by-products cater to cattle, poultry, fish, and animal feed industries.

  • Market Cap 57.8 Cr.
  • Current Price 64.6
  • High / Low 68.0 / 64.6
  • Stock P/E 20.4
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 18.7 %
  • ROE 19.8 %
  • Face Value 10.0

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
92.60 93.03 71.27 74.71
91.10 91.27 68.38 68.64
Operating Profit 1.50 1.76 2.89 6.07
OPM % 1.62% 1.89% 4.06% 8.12%
0.17 0.18 0.05 0.01
Interest 0.75 1.07 1.17 1.65
Depreciation 0.46 0.41 0.40 0.34
Profit before tax 0.46 0.46 1.37 4.09
Tax % 26.09% 28.26% 27.74% 30.56%
0.34 0.34 0.99 2.84
EPS in Rs 13.60 13.60 28.94 4.49
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -7%
TTM: 5%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 103%
TTM: 187%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 15%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2.50 2.50 3.42
Reserves 1.03 1.36 10.92
12.42 12.05 16.41
5.77 6.81 6.76
Total Liabilities 21.72 22.72 37.51
2.80 2.79 2.62
CWIP 0.17 0.17 0.00
Investments 0.00 0.00 9.49
18.75 19.76 25.40
Total Assets 21.72 22.72 37.51

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0.16 0.64 -3.90
0.06 -0.32 -9.43
0.56 -0.79 13.31
Net Cash Flow 0.46 -0.47 -0.02

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 23.57 10.04 29.76
Inventory Days 45.30 67.19 103.34
Days Payable 21.57 26.93 31.36
Cash Conversion Cycle 47.30 50.30 101.74
Working Capital Days 5.20 11.46 31.24
ROCE % 9.60% 10.89%

Shareholding Pattern

Numbers in percentages

Oct 2025
70.72%
1.47%
27.81%
No. of Shareholders 348

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Annual reports

No data available.